Companies/JP/4519

中外製薬株式会社 · CHUGAI PHARMACEUTICAL CO., LTD.

Income flow

Annual
4519 ANNUAL Income StatementPeriod 2025-12-31Source ANNUAL
Net salesJPY 1258B+8% Y/YRevenueJPY 1258B+8% Y/YGross profitJPY 894B+8% Y/YCost of revenueJPY 364BOperating profitJPY 599B+11% Y/YOperating expensesJPY 295BNet profitJPY 434B+12% Y/YTaxJPY 164BOperating expensesJPY 295B

As-filed revenue segments and annual P&L (gross, opex, tax, net). Layout inspired by SankeyArt finance diagrams.

Capital & dividends

YieldTrailing twelve-month dividends as a percent of the current share price (income yield).2.14%5y avgAverage dividend yield over the past five years — a smoother view than the latest print.1.62%Trailing DPSCash dividends paid per share over the last twelve months (dividend per share, trailing).138PayoutShare of earnings paid out as dividends. Higher means more income returned; lower leaves more for reinvestment.48.2%Shares outTotal shares currently outstanding (issued and not retired).1.65BFloatShares available to trade — outstanding minus closely held (insiders, strategic holders).639.4M
Upcoming dividend
Next ex-div
2026-12-29 · declared
Last cash
66 · 2026-12-29
Stock splits
  1. 3:12020-06-29